Loading...
VEGF-A splicing: the key to anti-angiogenic therapeutics?
The physiology of microvessels limits the growth and development of tumours. Tumours gain nutrients and excrete waste through growth-associated microvessels. New anticancer therapies target this microvasculature by inhibiting vascular endothelial growth factor A (VEGF-A) splice isoforms that promote...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2008
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2613352/ https://ncbi.nlm.nih.gov/pubmed/18923433 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrc2505 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|